Ka yi la'akari da Tsaro na Magunguna don Matsalolin Mawuyacin ciki yayin da ke da ciki
Idan kuna da wahala barci a lokacin da kuke ciki, kuna iya koyi game da zaɓuɓɓukan magani. Wasu yanayi kamar rashin barci da rashin ciwon kafafu (RLS) na iya faruwa sau da yawa a lokacin ciki. Sauran barcin barci irin su narcolepsy da halayen barci da aka sani da sifofi na iya kasancewa ta hanyar ciki da kuma buƙatar magani. Yana da mahimmanci a fahimci yadda amintaccen amfani da magunguna a lokacin hawan ciki an ƙayyade.
Bayan haka, zaku iya la'akari da abin da likitanku zai iya yi don magance yanayinku kuma ya taimake ku ku barci mafi alhẽri. Gano abin da magunguna suke da kyau don amfani da su don magance matsalar barci a ciki.
Categorizing Tsaro Drug
Hanya na farko da za a magance matsalar barci a cikin mace mai ciki shine yin amfani da canje-canje na rayuwa don taimakawa wajen kawar da yanayin kuma guje wa dukkan magunguna. Ga wadanda ke fama da rashin barci, magani tare da maganin halayyar rashin lafiya (CBTi) na iya zama mai tasiri. Koda a RLS, canje-canje iri-iri zai iya haifar da sauƙi ba tare da samun magani ba.
A cikin yanayi mai tsanani, dole ne a yi amfani da wasu magunguna tare da taka tsantsan. Damuwa ita ce, yawancin magunguna ba a gwada su a yawancin mata ba. Ba wanda yake so ya haifar da lalacewar haihuwa. Magunguna da suke yin haka ana kiransa teratogenic (fassara na ainihi ko "dodon gado"). Saboda haka, ba a yi nazari da yawa a cikin mata masu ciki ba ko da an yi la'akari da ƙananan haɗari a matsayin mai karɓa.
Duk da haka, kwarewa da karatu a cikin dabbobi sun ba mu shiriya game da lafiyar lafiyar ciki.
Bayanan da aka tsara na magunguna a lokacin daukar ciki ana amfani dashi:
- Bangaren B : Nazarin dabbobi ba su nuna haɗarin tayi ba amma babu nazari akan nazari akan mata masu ciki, ko nazarin dabba sun nuna tasirin tayin da ba'a tabbatarwa a nazarin karatun mata a cikin farkon jim kadan. Babu wani shaida a cikin wasu kwatsam na baya.
- C-C : Nazarin dabbobi sun nuna abubuwan da ke faruwa a cikin tayi, amma babu wani binciken nazari akan mata masu ciki, ko nazari akan mutane da dabbobi ba su samuwa; Saboda haka, ana bada magani idan amfana mai yawa ya fi hadarin.
- Category D : Hadarin zuwa tayin ba a nan ba, amma amfanin zai iya wuce hadarin idan hadarin barazana ko mummunan cuta ya wanzu.
- Category X : Nazarin dabbobi ko mutane suna nuna alamun mahaukaci; an haramta maganin miyagun ƙwayoyi ga mata masu juna biyu.
Saboda haka, magunguna suna zaton sun kasance mafi aminci yayin da ƙarin bincike da ke taimakawa kare lafiya a cikin mutane yana samuwa. Duk da haka, haɗarin mutum tare da yin amfani da duk wani miyagun ƙwayoyi zai iya haifar da sakamakon da ba a yarda ba.
Amfani da miyagun ƙwayoyi don rashin barci
Yin amfani da kundin da aka tsara a sama, magunguna don magance matsalar barci mafi yawan lokuta a lokacin ciki za a iya haɗuwa. Wadannan sharuɗɗa sun haɗa da barci, RLS, narcolepsy, da sauransu. Tsaro na ƙwayoyi suna ragu yayin da kake motsawa daga Category B zuwa Category C zuwa Category D kuma, a ƙarshe, zuwa Category X. Yi la'akari da magungunan barci a lokacin ciki don kowane yanayin da ya biyo baya:
Insomnia
Category B
Magunguna da Magunguna (Benzodiazepines): Zolpidem , Diphenhydramine
Category C
Ma'aikata da Harkokin Kifi (Benzodiazepines): Zaleplon
Anticonvulsants: Gabapentin
Magungunan antidepressants da masu damuwa: Amitriptyline, Doxepin, Trazodone
Category D
Ma'anar Sedatives da Hypnotics (Benzodiazepines): Barasa , Alprazolam, Diazepam, Lorazepam, Midazolam, Secobarbital
Category X
Magunguna da Harkokin Kifi (Benzodiazepines): Barasa (idan aka yi amfani da shi mai yawa ko tsawon lokaci), Estazolam, Flurazepam, Quazepam, Temazepam, Triazolam
Ƙunƙasar Ciwon Ƙunƙasa ko Ƙungiyar Willis-Ekbom
Category B
Antiparkinsonian Agents (Dopaminergics): Bromocriptine, Cabergoline
Narcotic Agonist Analgesics (Opioids) (duba D): Meperidine, Oxymorphone, Methadone, Oxycodone
Category C
Magunguna na tsakiya: Clonidine
Anticonvulsants: Gabapentin, Lamotrigine
Antiparkinsonian Agents (Dopaminergics): Carbidopa, Levodopa, Pramipexole , Ropinirole
Narcotic Agonist Analgesics (Opioids) (duba D): Codeine, Morphine, Propoxyphene, Hydrocodone Antidepressants and Depressants: Amitriptyline, Doxepin, Trazodone
Category D
Anticonvulsants: Clonazepam, Carbamazepine
Narcotic Agonist Analgesics (Opioids) (idan an yi amfani dashi tsawon lokaci ko a cikin dogaye a lokaci): Meperidine, Oxymorphone, Methadone, Oxycodone, Codeine, Morphine, Propoxyphene, Hydrocodone
Category X
Ma'aikatan Sedatives da Hypnotics (Benzodiazepines): Estazolam, Flurazepam, Quazepam, Temazepam, Triazolam
Narcolepsy
Category B
Madafi: Caffeine, Permoline
Antidepressants da Depressants: Sodium oxybate (Xyrem)
Category C
Antidepressants da Depressants: Fluoxetine, Paroxetine, Protriptyline, Venlafaxine
Masu jaruntaka: Dextroamphetamine, Mazindol, Methamphetamine, Methylphenidate, Modafinil
Category D
Babu
Category X
Babu
Sa'idodi (Maganar Barci)
Category B
Babu
Category C
Antidepressants da Depressants: Imipramine, Paroxetine, Sertraline, Trazodone
Category D
Ma'anoni da Harkokin Kifi (Benzodiazepines): Diazepam
Anticonvulsants: Clonazepam, Carbamazepine
Category X
Babu
Yadda za a zabi magani
Bayan yin la'akari da jerin magungunan da ake samu don magance matsalar barci a lokacin daukar ciki, ya kamata ka yi bayani game da halinka tare da likitanka. Kuna so kuyi la'akari da tsananin karfinku. Kuna buƙatar magani ko kuma yanayin zai wuce kansa? Idan za ta yiwu, ya kamata ka fara gwada maganin marasa magani wanda ya hada da canje-canje na rayuwa. Idan zaka iya magance matsalolin, sauya abincinka, ko inganta yanayinka tare da motsa jiki, mai yiwuwa bazai buƙaci ka yi la'akari da magani mai mawuyaci.
Idan ka yanke shawarar zaɓar yin amfani da magani a yayin da kake ciki, tattauna kan yiwuwar hadari tare da likitanka da likitan mai magani don tabbatar da an sanar da kai game da sakamakon da ya dace. Kuna iya zama mai ba da shawara mafi kyau, duka da kanka da yaronka ba a haifa ba.
Source:
Kryger, MH et al . "Ka'idoji da Kwarewar Magunguna." Kwararren Kwararru , 5th edition, 2011, p. 1581.